Ebb Therapeutics developed a first-of-its-kind, wearable sleep mask that used a proprietary cooling technology to help people fall asleep faster and stay asleep longer. Before bringing the product to market, Ebb partnered with Campos to test it among users to inform product improvements and marketing strategies.

Occupying a unique space between traditional market research and clinical trials, we created sleep labs, mock bedrooms, and at-home trials to test the product in many ways over extended periods of time. These engagements included both qualitative and quantitative research.

In one early study, for example, we focused on how people unboxed the device. How did they set it up? Where? Did they refer to the user manual or not? At which points did they struggle? How could the experience be improved?

In the later stages of product iteration, we worked with Ebb to track how customers used the device in their own homes. We recruited respondents who met stringent inclusion and exclusion criteria, both nationally and regionally, and then administered daily diary surveys over baseline and trial periods. This data was then used to inform one-on-one interviews at the conclusion of the trial, allowing us to probe respondents for additional context on their experience.

Through this ongoing cycle of quantitative and qualitative research, Campos provided Ebb the data-backed insight they needed to iterate on their product design. Our guidance helped lead the company to successful launches of several generations of products and put them into position for a $38 million acquisition.